Denosumab
Trade Name:
Xgeva
Manufacturer/Distributor:
Amgen
1-866-502-6436
Classification:
Bone resorption inhibitor
ATC Class:
M05BX04 - Denosumab
Status:
active
Notice of Compliance (yyyy/mm/dd):
2011/05/10
Date Marketed in Canada (yyyy/mm/dd):
2011/10/05
Presentation:
Injection: 120 mg/1.7 mL prefilled syringe. DIN: 02368153
Comments:
Xgeva is a RANK Ligand inhibitor intended for use in advanced cancer (reduces the risk of developing skeletal-related events in patients with bone metastases from breast cancer, prostate cancer, non-small cell lung cancer and other solid tumors.
| Posted | Updated |
|---|---|
| 2011-10-17 13:58 | 2011-10-17 14:01 |
